- Conditions
- Anterior Cutaneous Nerve Entrapment Syndrome
- Interventions
- Abdominal wall injections with lidocaine 2%
- Drug
- Lead sponsor
- Oregon Health and Science University
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 45 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2025
- U.S. locations
- 2
- States / cities
- Portland, Oregon
Source: ClinicalTrials.gov public record
Updated Sep 1, 2025 · Synced May 22, 2026, 12:15 AM EDT